LYMPHIR

DENILEUKIN DIFTITOX-CXDL · Citius Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LYMPHIR, covering 2024-08-07 to 2024-08-07. Get the full timeline:

Most recent: FDA Approved: LYMPHIR — Original Application (Citius Pharmaceuticals, Inc.)